Keywords: strong, first, quarter, r-pr, franco-american, drug, company
STRONG FIRST QUARTER FOR R-PR
Article | 26 April 1993
Franco-American drug company Rhone-Poulenc Rorer has posted strong results for the first quarter of 1993. Sales grew 7% to $916 million, excluding currency ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
